Mittwoch | Mercredi 02.06.2010Zur Tagesübersicht | ||
09:45-10:00 San Francisco - Plenum | Eröffnung C. W. Hess, Bern, Tagungspräsident C. Bassetti, Lugano/Zürich, Präsident SFCNS | |
10:00-11:20 |
SFCNS Stroke campaign 2010 - Part I | |
| 10:00-10:40 | Intracranial aneurysms: new aspects of formation, rupture and outcome A. Raabe, Bern | |
| 10:40-11:20 | Intracerebral haemorrhage K. Schaller, Genève | |
| 11:20-11:45 | Kaffeepause in der Industrieausstellung | |
11:45-13:00 San Francisco - Plenum | SFCNS Stroke campaign 2010 - Part II Main session Cerebrovascular disorders and stroke Chair: H. Mattle, Bern, K. Lövblad, Genève | |
| 11:45-12:20 | New insights in the pathophysiology of stroke G. A. Donnan, Melbourne; Australia | |
| 12:20-13:00 | Arteriovenous malformations: to treat or not to treat – will ARUBA solve this question? Ch. Stapf, Paris; France | |
| 13:00-14:30 | Lunch in der Industrieausstellung | |
13:00-14:30 Raum Montreal |
Controversies in Neurology | |
| 13:15-13:25 | Treatment of trigeminal neuralgia Microvascular decompression is the first line treatment V. Rohde, Göttingen; Germany | |
| 13:25-13:35 | Pharmacological and percutaneous methods should be used first P. Sandor, Zurich; Switzerland | |
| 13:35-13:45 | Discussion | |
| 13:45-13:55 | Management of multiple sclerosis Interferons and glatiramer acetate are effective and safe Ch. Kamm, Bern; Switzerland | |
| 13:55-14:05 | There are more effective newer drugs L. Airas, Turku; Finland | |
| 14:05-14:15 | Discussion and Closure | |
| 14:30-16:00 Raum Montreal | SFCNS Stroke campaign 2010 - Part III Afternoon session A: Cerebrovascular disorders and stroke Organisation: Schweizerische Hirnschlag Gesellschaft SHG - ww.neurovasc.ch Schweizerische Gesellschaft für Neuroradiologie SGNR Chair: C. Bassetti, Lugano/Zürich, Ph. Lyrer, Basel | |
| 14:30-15:00 | New techniques for diagnosis of cerebrovascular disorders J. Fiehler, Hamburg; Germany | |
| 15:00-15:30 | Conservative treatment of stroke and IV-thrombolysis P. Michel, Lausanne | |
| 15:30-16:00 | Endovascular treatment of acute stroke J. Gralla, Bern | |
| 14:30-16:00 Raum Singapore | Afternoon session B: Muscular dystrophies Organisation: Schweizerische Gesellschaft für Muskelkranke SGMK Chair: M. Steinlin, Bern, Th. Kuntzer, Lausanne | |
| 14:30-15:00 | Muscular dystrophies, clinical aspects Clinical phenotypes in children A. Klein, Zürich Clinical phenotypes in adults D. Fischer, Basel | |
| 15:00-15:30 | Muscular dystrophies, pathology and genetics Myopathology M. Tolnay, Basel Molecular genetic testing F. Joncourt, Bern | |
| 15:30-16:00 | Muscular dystrophies, therapeutic strategies and clinical trials Molecular basis of therapeutic strategies M. Sinnreich, Basel Ongoing clinical trials P.-Y. Jeannet, Lausanne | |
| 14:30-16:00 Raum Sydney | Afternoon session C: Topics in neurorehabilitation Organisation: Schweizerische Gesellschaft für Neurorehabilitation SGNR Chair: R. Müri, Bern, F. Baronti, Tschugg | |
| 14:35-15:00 | Cell therapy and stroke J. Bloch, Lausanne | |
| 15:00-15:25 | Therapiestrategien bei Hemispastik Ch. Kätterer, Basel | |
| 15:25-15:50 | Schluckstörungen nach Stroke K. Schweikert, Basel | |
| 15:50-16:00 | Zusammenfassung R. Müri, Bern, F. Baronti, Tschugg | |
| 16:00-16:30 | Kaffeepause in der Industrieausstellung | |
16:30-17:30 San Francisco - Plenum | SFCNS Gründungszeremonie Leitung: C. Bassetti, Lugano/Zürich Grussworte:
| |
| 17:30-18:15 | Cocktail in der Industrieausstellung mit musikalischem Rahmenprogramm von Acoustic Jazz Trio aus Basel. | |
| 18:00-19:15 Raum Montreal | Generalversammlung SNG | |
| ab 19:30 | Festliches Dinner anlässlich der SFCNS Gründung
| |
| zurück | ||
 | ||